Myriad Genetics Inc
MYGN- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000899923
No open-market purchases or sales by Myriad Genetics Inc insiders were filed in the last 90 days; 196 institutions reported holding it in 13F filings for Q2 2026, worth $507.8M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Myriad Genetics Inc as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 201
- +5 vs. Q1 2021
- Shares held
- 75.5M
- +1.76M (+2.4%) vs. Q1 2021
- Total value
- $2.31B
- +$64.1M (+2.9%) vs. Q1 2021
- New holders
- 27
- 71 more added
- Sold out
- 22
- 61 more reduced
1 institution that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MYGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 196 | $507.8M |
| Q1 2026 | 204 | $519.2M |
| Q4 2025 | 221 | $567.1M |
| Q3 2025 | 221 | $639.8M |
| Q2 2025 | 221 | $480.5M |
| Q1 2025 | 228 | $832.9M |
| Q4 2024 | 221 | $1.27B |
| Q3 2024 | 246 | $2.48B |
| Q2 2024 | 223 | $2.25B |
| Q1 2024 | 186 | $2.00B |
| Q4 2023 | 194 | $1.72B |
| Q3 2023 | 186 | $1.33B |
| Q2 2023 | 188 | $1.88B |
| Q1 2023 | 190 | $1.91B |
| Q4 2022 | 196 | $1.17B |
| Q3 2022 | 191 | $1.55B |
| Q2 2022 | 199 | $1.46B |
| Q1 2022 | 205 | $1.99B |
| Q4 2021 | 197 | $2.16B |
| Q3 2021 | 213 | $2.56B |
| Q2 2021 | 201 | $2.31B |
| Q1 2021 | 197 | $2.25B |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Myriad Genetics Inc; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Fieldpoint Private Securities, LLC | 5 | $0 | 0.00% | −30−85.7% | Reduced |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −213,566−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| California Public Employees Retirement System | 0 | $0 | 0.00% | −145,900−100.0% | Sold out |
| Mackay Shields LLC | 0 | $0 | 0.00% | −60,931−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −55,845−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −47,802−100.0% | Sold out |
| Migdal Insurance & Financial Holdings Ltd. | 0 | $0 | 0.00% | −36,322−100.0% | Sold out |
| True Link Financial Advisors, LLC | 0 | $0 | 0.00% | −23,611−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −11,760−100.0% | Sold out |
| Brookfield Asset Management Inc. | 0 | $0 | 0.00% | −11,438−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −9,974−100.0% | Sold out |
| ETF Managers Group, LLC | 0 | $0 | 0.00% | −9,405−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −2,510−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −1,950−100.0% | Sold out |
| Altshuler Shaham Ltd | 0 | $0 | 0.00% | −1,341−100.0% | Sold out |
| Wealthcare Advisory Partners LLC | 0 | $0 | 0.00% | −1,205−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −630−100.0% | Sold out |
| Valeo Financial Advisors, LLC | 0 | $0 | 0.00% | −513−100.0% | Sold out |
| Eudaimonia Partners, LLC | 0 | $0 | 0.00% | −521−100.0% | Sold out |
| Benjamin F. Edwards & Company, Inc. | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Wealthcare Capital Management LLC | 0 | $0 | 0.00% | −43−100.0% | Sold out |
| Amundi Asset Management US, Inc. | – | – | – | – | Not filed |